COVID-19 immunity and vaccines could be key to fighting breast cancer, a researcher says.
Dr Clare Slaney is focused on improving chimeric antigen receptor (CAR) T-cell therapy—a type of immunotherapy whereby doctors collect a small portion of a patient’s T-cells, which are an important part of the immune system.
The cells have the ability to track down and destroy abnormal cells, including some cancer cells, and the therapy has them re-engineered in labs to carry special anti-cancer molecules called chimeric antigen receptors, or CARs, on their surface.
The cells then rapidly multiply when they are injected back into a patient. …